Lv2
130 积分 2025-04-25 加入
A Multicenter Real-Life Evaluation of Safety and Effectiveness of the Antibody-Drug Conjugate Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer
10天前
已完结
Retrospective, Observational Analysis of Real-World Safety Outcomes in Patients With Locally Advanced/Metastatic Urothelial Cancer Treated With Sacituzumab Govitecan
12天前
已完结
Prophylactic use of G-CSFs to reduce neutropenia rates in patients treated with antibody–drug conjugates: A literature review
12天前
已完结
Ifebemtinib plus garsorasib in previously treated metastatic colorectal cancer with KRASG12C mutation: a multicentre, randomised, phase 1b/2 trial
23天前
已完结
A Prospective Study of Olanzapine and Aprepitant for CINV in Cisplatin-HAIC for Hepatocellular Carcinoma (PROACT)
1个月前
已关闭
Clinical benefits of adding olanzapine to 5-HT3 receptor antagonist, NK1 receptor antagonist, and dexamethasone for the prevention of nausea and vomiting in highly emetogenic chemotherapy: a systematic review and meta-analysis of the Clinical Practice Guidelines for Antiemesis 2023 from the Japan Society of Clinical Oncology
1个月前
已完结
Impact of Comorbidity on Antiemetic Efficacy in Patients with Esophageal Cancer Treated with Cisplatin-Based Chemotherapy: A Retrospective Study from Japan
1个月前
已关闭
Enhanced recovery after surgery (ERAS®) society guidelines for gynecologic oncology: 2026 update
1个月前
已完结
Casopitant and Ondansetron for Postoperative Nausea and Vomiting Prevention in Women at High Risk for Emesis
1个月前
已关闭
Sacituzumab Govitecan plus Pembrolizumab for Advanced Triple-Negative Breast Cancer
1个月前
已完结
皖公网安备34019202002308
